학술논문
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
Document Type
article
Author
Daniela Manno; Philip Ayieko; David Ishola; Muhammed O. Afolabi; Baimba Rogers; Frank Baiden; Alimamy Serry-Bangura; Osman M. Bah; Brian Köhn; Ibrahim Swaray; Kwabena Owusu-Kyei; Godfrey T. Otieno; Dickens Kowuor; Daniel Tindanbil; Elizabeth Smout; Cynthia Robinson; Babajide Keshinro; Julie Foster; Katherine Gallagher; Brett Lowe; Macaya Douoguih; Bailah Leigh; Brian Greenwood; Deborah Watson-Jones
Source
Emerging Infectious Diseases, Vol 28, Iss 3, Pp 734-738 (2022)
Subject
Language
English
ISSN
1080-6040
1080-6059
22540717
1080-6059
22540717
Abstract
We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014–2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased with age.